Activation of thousands of latent 5'SSs in stress and cancer enabled us to search for characteristics of latent 5'SSs and especially to compare those latent sites that were activated in stress and cancer to those that were not. First, we compared the length distribution of the latent exons that were activated in stress and cancer to those that were not, and we did not find a significant difference (Supplementary Figure S3) . Next, we analyzed the length distribution of the extended latent exons (the latent exon combined with its upstream authentic exon), which represent the new exons resulting from activation of latent splicing. When we compared the length distribution of authentic exons with that of extended latent exons (from all the analyses of stress and disease), we can see that only ~8% of the authentic exons are above 1,000 nt long (Supplementary Figure S4) . This justifies the cut-off of 1,000 nt for the length of latent exons analyzed in this study. The finding that ~8% of the activated latent exons (Supplementary Figure   S3 ) are between 901-1,000 nt is in further support of this cut-off. Comparing the length distribution of the extended latent exons that were activated to those that were not we find a very significant difference between the two groups. The main contribution comes from the larger fraction of non-activated extended latent exons of length above 1,000 nt, yet ~15% of the activated extended latent exons are longer than 1,000 nt. We can therefore conclude that, up to 1,000 nt, the length of the latent exon is not an essential factor in determining if a latent site will be activated or not.
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Our previous 5'SS sequence analysis had shown that the consensus for the latent 5'SSs was not significantly different from that of the authentic ones (4) . Because this analysis used a relatively small data set and a different criterion for the assignment of latent 5'SSs, we repeated here this analysis using a much larger database and a more stringent criterion (a cut-off of ~87.2 for the Shapiro and Senapathy (S&S) splice site score (5) of latent 5'SSs). Furthermore, in the present study we analyzed the score distribution of latent sites that were activated in stress and cancer and compared it with the score distribution of latent sites that were not activated. In supplementary Figure S5A we compare the S&S score distribution for all authentic 5'SSs, all latent 5'SSs and those latent sites that were either activated or not in stress and disease. As we selected a cut-off of ~87.2 for the score of latent 5'SSs, the majority of latent 5'SSs (~80%), weather activated or not, range between 87-92, and there is no significant difference between the score distribution of latent 5'SSs that were activated in stress and cancer and those that were not activated (Supplementary Figure S5A) . Thus, a more stringent cut-off would not have discriminated activated (confirmed) latent 5'SSs from non-activated ones. Also, when we compared the sequence pattern, represented as a pictogram of the weight matrices of all the latent sites activated in stress and cancer with that of non-activated ones (Supplementary Figure S5B) , no significant differences were detected (χ 2 test with the Bonferroni correction).
However, when we take into consideration each latent site with its upstream authentic 
